Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval.
Pharmacogenomics J
; 14(1): 6-13, 2014 Feb.
Article
em En
| MEDLINE
| ID: mdl-23459443
ABSTRACT
Variability in response to drug use is common and heritable, suggesting that genome-wide pharmacogenomics studies may help explain the 'missing heritability' of complex traits. Here, we describe four independent analyses in 33 781 participants of European ancestry from 10 cohorts that were designed to identify genetic variants modifying the effects of drugs on QT interval duration (QT). Each analysis cross-sectionally examined four therapeutic classes thiazide diuretics (prevalence of use=13.0%), tri/tetracyclic antidepressants (2.6%), sulfonylurea hypoglycemic agents (2.9%) and QT-prolonging drugs as classified by the University of Arizona Center for Education and Research on Therapeutics (4.4%). Drug-gene interactions were estimated using covariable-adjusted linear regression and results were combined with fixed-effects meta-analysis. Although drug-single-nucleotide polymorphism (SNP) interactions were biologically plausible and variables were well-measured, findings from the four cross-sectional meta-analyses were null (Pinteraction>5.0 × 10(-8)). Simulations suggested that additional efforts, including longitudinal modeling to increase statistical power, are likely needed to identify potentially important pharmacogenomic effects.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Farmacogenética
/
Síndrome do QT Longo
/
Característica Quantitativa Herdável
/
Polimorfismo de Nucleotídeo Único
/
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
/
Interação Gene-Ambiente
Tipo de estudo:
Health_economic_evaluation
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limite:
Humans
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article